Abstract The invention provides compounds of the formula (I) <IMAGE> (I) or salts, esters, or amides or other protected forms thereof; wherein R1 is a C1-7 bivalent aliphatic hydrocarbon group or a single bond; R2 and R3 are the same or different and are each hydrogen, C1-4 alkyl or taken together with the nitrogen comprise a nitrogen-containing heterocyclic ring having four to six ring members; X is -N= or -CH=; A and B each represent hydrogen atoms or -CA-CB- represents -C=C-; and D is an acidic group other than a carboxylic acid group. Also provided are pharmaceutical compositions of compounds of the formula (I), methods for the preparation of the compounds and intermediates in their preparation. The compounds of the formula (I) have antihistamic activity.
A pharmaceutically acceptable salt of 5-(E-6-[3-pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridylvinyl)-1H-tetrazole.
Claim 4
Dependent Claim
6 words
A pharmaceutically acceptable salt of 5-(E-6-[3-pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridylvinyl)-1H-tetrazole.
Claim 5
Independent Claim
33 words
A method of obtaining an antihistaminic effect in a mammal in need thereof comprising administration to said mammal of an effective antihistiminic amount of the compound 5-(E-6-[3-Pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridylvinyl)-1H-tetrazole or a pharmaceutically acceptable salt thereof.
Claim 6
Independent Claim
33 words
A method of obtaining an antihistaminic effect in a mammal in need thereof comprising administration to said mammal of an effective antihistiminic amount of the compound 5-(E-6-[3-Pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridylvinyl)-1H-tetrazole or a pharmaceutically acceptable salt thereof.